Regulatory PathRegulatory requirements compared

Active substance

Albumin human

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
ALBUTEIN 20% SOLN. FOR INJ20 %Intravenous infusion · Intravenous use1 VialSAR 146.40Biological · PrescriptionGRIFOLS BIOLOGICALS LLCValid
Albumin SK20 %Solution for injection · Intravenous use1 VialSAR 164.45Biological · PrescriptionSK Plasma Co. LtdValid
Albumin SK20 %Solution for injection · Intravenous use1 VialSAR 314.60Biological · PrescriptionSK Plasma Co. LtdValid
Alburex200 g/lSolution · Intravenous use1 VialSAR 249.10Biological · PrescriptionCSL BEHRINGValid
Alburex200 g/lSolution · Intravenous use1 VialSAR 154.95Biological · PrescriptionCSL BEHRINGValid
FLEXBUMIN 200GM/L SOLUTION FOR INFUSION200 g/lSolution for infusion · Intravenous use1 BagSAR 156.55Biological · PrescriptionTakeda Manufacturing AGValid
FLEXBUMIN 200GM/L SOLUTION FOR INFUSION200 g/lSolution for infusion · Intravenous use1 BagSAR 285.85Biological · PrescriptionTakeda Manufacturing AGValid
HUMAN ALBUMIN 20%20 %Solution · Intravenous use1 VialSAR 146.40Biological · PrescriptionOCTAPHARMAValid
HUMAN ALBUMIN 20%20 %Solution · Intravenous use1 BottleSAR 213.85Biological · PrescriptionOCTAPHARMAValid
HUMAN ALBUMIN 20% +INFUSION SET20 %Solution · Intravenous use1 VialSAR 138.55Biological · PrescriptionBIOTESTValid
HUMAN ALBUMIN 20% +INFUSION SET20 %Solution · Intravenous use1 BottleSAR 262.90Biological · PrescriptionBIOTESTValid
HUMAN ALBUMIN 20% SOLUTION FOR INFUSION20 %Solution · Intravenous use1 VialSAR 164.45Biological · PrescriptionHUMAN BioPlazma LLCValid
HUMAN ALBUMIN 20% SOLUTION FOR INFUSION20 %Solution · Intravenous use1 VialSAR 314.60Biological · PrescriptionHUMAN BioPlazma LLCValid
HUMAN ALBUMIN 200G-I TAKEDA20 %Solution · Intravenous use1 VialSAR 141.00Biological · PrescriptionTakeda Manufacturing AGValid
HUMAN ALBUMIN 5%5 %Solution · Intravenous use1 BottleSAR 187.05Biological · PrescriptionOCTAPHARMAValid
HUMAN ALBUMIN 5%5 %Solution · Intravenous use1 BottleSAR 190.60Biological · PrescriptionBIOTESTValid
HUMAN ALBUMIN 50G-I TAKEDA 250ML5 %Solution · Intravenous use1 BottleSAR 209.55Biological · PrescriptionTakeda Manufacturing AGValid
Human Albumin Grifols 20%20 %Solution for infusion · Intravenous use1 VialSAR 213.85Biological · PrescriptionInstituto Grifols, S.AValid
Human Albumin Grifols 20%20 %Solution for infusion · Intravenous use1 VialSAR 146.40Biological · PrescriptionInstituto Grifols, S.AValid
PLASBUMIN 20%20 %Suspension for injection · Intravenous use1 VialSAR 146.40Biological · PrescriptionGRIFOLS THERAPEUTICS INCValid
PLASBUMIN 20%20 %Suspension for injection · Intravenous use1 VialSAR 213.85Biological · PrescriptionGRIFOLS THERAPEUTICS INCValid
UMAN ALBUMIN 20% SOLUTION FOR INFUSION20 %Solution · Intravenous use1 VialSAR 122.75Biological · PrescriptionKEDRIONValid
UMAN ALBUMIN 20% SOLUTION FOR INFUSION20 %Solution · Intravenous use1 BottleSAR 245.50Biological · PrescriptionKEDRIONValid
ALBUMINATIVE 20% I.V.20 %Solution · Intravenous use1 VialSAR 215.25Biological · PrescriptionOCTAPHARMAWithdrawn by MAH · Not Marketed
ALBUMINATIVE 20% I.V.20 %Solution · Intravenous use1 BottleSAR 300.70Biological · PrescriptionOCTAPHARMAWithdrawn by MAH · Not Marketed

9 more — full table

Indications — CHI Daman Drug Formulary

BURN MANAGEMENT; LIVER CIRRHOSIS; Septic Shock

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
OPTISON10MG/MLinjectable · injectionGE HEALTHCAREPrescription31 Dec 1997

Safety signals and safety-related labeling changes

All safety entries for albumin human →

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.